Rocket Pharmaceuticals, Inc.
RCKT
$4.87
$0.142.96%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.98% | -26.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.00% | -22.55% | |||
| Operating Income | 16.00% | 22.55% | |||
| Income Before Tax | 15.49% | 26.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.49% | 26.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.49% | 26.97% | |||
| EBIT | 16.00% | 22.55% | |||
| EBITDA | 14.98% | 24.46% | |||
| EPS Basic | 15.65% | 27.34% | |||
| Normalized Basic EPS | 16.18% | 23.26% | |||
| EPS Diluted | 15.65% | 27.34% | |||
| Normalized Diluted EPS | 16.18% | 23.26% | |||
| Average Basic Shares Outstanding | 0.19% | 0.50% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||